Welcome to our dedicated page for Keysight Technologies SEC filings (Ticker: KEYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keysight Technologies filings document the regulatory record for an NYSE-listed test and measurement technology company with common stock trading under KEYS. Recent Form 8-K reports cover quarterly and fiscal-year financial results, non-GAAP reconciliations, investor presentations related to acquisitions, and material financing arrangements.
The company’s proxy and annual-meeting disclosures address director elections, auditor ratification, executive compensation votes, board structure, stockholder proposals and governance matters. Other current reports document board appointments, executive transitions, credit-agreement terms, revolving-credit capacity, covenant requirements and related capital-structure obligations.
Ingrid A. Estrada, Senior Vice President of Keysight Technologies (KEYS), reported an insider sale. She disposed of 2,000 shares of Keysight common stock on 09/17/2025 at a reported price of $173.98 per share. Following this transaction she is reported to beneficially own 106,590.19 shares. The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Insider sale reported for Keysight Technologies (KEYS). Lisa M. Poole, Vice President and Controller, reported a sale of 142 shares of Keysight common stock on 09/17/2025 at a price of $173.56 per share. After the sale she beneficially owned 4,646 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/19/2025.
Form 144 notice for Keysight Technologies, Inc. (KEYS): The filer notifies a proposed sale of 2,000 common shares through Fidelity Brokerage Services with an aggregate market value of $347,960.20, to be sold approximately on 09/17/2025 on the NYSE. The filing shows the shares were acquired by restricted stock vesting: 355 shares on 11/14/2021, 863 on 11/18/2022, and 782 on 11/20/2022, all as compensation. It also discloses a recent sale by the same person, Ingrid A. Estrada, of 10,000 shares on 06/20/2025 for gross proceeds of $1,589,682.42. The signer certifies they are not aware of undisclosed material adverse information about the issuer.
Form 144 filed for Keysight Technologies, Inc. (KEYS) discloses a proposed sale of 142 shares of common stock through Fidelity Brokerage Services, with an approximate aggregate market value of $24,645.53. The filing lists the approximate date of sale as 09/17/2025 on the NYSE. The shares were acquired as restricted stock vesting on 11/27/2019 (139 shares) and 11/28/2019 (3 shares) and were received as compensation. The filer reports no securities sold in the past three months and attests that they are not aware of any undisclosed material adverse information about the issuer.
Keysight Technologies, Inc. reported condensed 10-Q disclosures for the quarter ended July 31, 2025 showing steady operating trends and several material financing, tax and acquisition items. The company completed the acquisition of ESI Group (controlling interest acquired Nov 3, 2023; remaining shares acquired Jan 2024) and presents pro forma results and integration-related amortization. Disaggregated revenue is reported by region, end market and timing, with remaining performance obligations of approximately $529 million (22% expected in 2025, 43% in 2026, 35% thereafter). Gross margin was flat for the quarter and down one percentage point year-to-date. R&D expense rose 11% (quarter) and 9% (nine months). Net income for the nine months decreased by $70 million. Cash and equivalents were $191 million. The company repurchased 1.79 million shares for $275 million in the nine months and has $210 million remaining under its $1.5 billion repurchase authorization. Debt fair value totaled ~$2,532 million as of July 31, 2025; Keysight issued 2030 Senior Notes and has a $750 million revolver with no outstanding borrowings. Keysight filed a lawsuit seeking a $107 million tax refund related to GILTI treatment; an adverse outcome would likely materially increase its effective tax rate.
Keysight Technologies furnished a Form 8-K stating that on August 19, 2025 the company issued a press release reporting financial results for the third fiscal quarter ended July 31, 2025, and that the press release is attached as Exhibit 99.1. The filing explains the company provides non-GAAP financial measures to supplement GAAP results so investors can view performance "through the eyes" of management, noting non-GAAP measures exclude items such as amortization of acquisition-related balances, share-based compensation, acquisition and integration costs, restructuring and other one-time adjustments. The company clarifies this non-GAAP information is not an alternative to GAAP and may differ from non-GAAP measures used by other companies. Additional explanation of the non-GAAP information is included in Exhibit 99.1.